Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yiqi Wenjing Prescriptions for Preventing Oxaliplatin-induced Peripheral Neuropathy
NCT04690283Phase 3Unknown
- Sponsor
- Nanjing Ningqi Pharmaceutical Technology
- Start
- Jan 2021
- Primary completion
- Jul 2022
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 3 trial of huang qi gui zhi wu wu tang, danggui sini, sponsored by Nanjing Ningqi Pharmaceutical Technology. Status: unknown.
02
Drugs
huang qi gui zhi wu wu tangdanggui sini
Beyond the preview
Go deeper on NCT04690283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04690283.